OFI Invest Asset Management Raises Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• OFI Invest Asset Management has increased its holdings in HCA Healthcare, Inc. by 9.4%, now owning 63,826 shares valued at approximately $24.45 million.
• Wall Street analysts have given HCA Healthcare an average rating of "Moderate Buy" with a target price of $422.31, while several firms have adjusted their price objectives significantly upwards.
• HCA Healthcare recently announced a quarterly dividend of $0.72 per share, which translates to an annualized yield of 0.7%.

OFI Invest Asset Management lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 9.4% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 63,826 shares of the company's stock after buying an additional 5,483 shares during the quarter. OFI Invest Asset Management's holdings in HCA Healthcare were worth $24,452,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of HCA. ORG Partners LLC grew its stake in HCA Healthcare by 27.9% in the second quarter. ORG Partners LLC now owns 142 shares of the company's stock worth $55,000 after purchasing an additional 31 shares in the last quarter. Avantax Advisory Services Inc. grew its stake in HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after purchasing an additional 32 shares in the last quarter. Glenview Trust co grew its stake in HCA Healthcare by 2.3% in the first quarter. Glenview Trust co now owns 1,451 shares of the company's stock worth $501,000 after purchasing an additional 32 shares in the last quarter. Horizon Investments LLC grew its stake in HCA Healthcare by 1.1% in the first quarter. Horizon Investments LLC now owns 3,175 shares of the company's stock worth $1,097,000 after purchasing an additional 33 shares in the last quarter. Finally, Sivia Capital Partners LLC grew its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company's stock worth $241,000 after purchasing an additional 33 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on HCA shares. Weiss Ratings reaffirmed a "buy (b-)" rating on shares of HCA Healthcare in a research report on Wednesday. JPMorgan Chase & Co. boosted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the company a "neutral" rating in a report on Monday, August 4th. Royal Bank Of Canada cut their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Barclays boosted their target price on HCA Healthcare from $390.00 to $445.00 and gave the stock an "overweight" rating in a report on Thursday, September 18th. Finally, Bank of America increased their price objective on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research report on Wednesday, September 10th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and nine have assigned a Hold rating to the company's stock. According to MarketBeat, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $422.31.

HCA Healthcare Stock Down 1.0%

NYSE HCA opened at $414.73 on Friday. The firm has a market cap of $97.04 billion, a P/E ratio of 17.43, a P/E/G ratio of 1.31 and a beta of 1.40. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $439.01. The business's 50-day moving average price is $405.12 and its 200 day moving average price is $375.85.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter last year, the firm earned $5.50 earnings per share. The firm's revenue was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is 12.11%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.